SARS-CoV-2 vaccinations reduce the prevalence of post-COVID Guillain-Barre syndrome Josef Finsterer; Daniel Matovu; Fulvio A. Scorza;

Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients Josef Finsterer; Fulvio A. Scorza; Carla A. Scorza;

The new variant c.458C>G in CHRNA1 causes late-onset post-synaptic slow-channel congenital myasthenic syndrome Josef Finsterer; Fulvio A. Scorza; Carla A. Scorza; Ana C. Fiorini;